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Multi-organ failure contributes to mortality in bacte-
rial sepsis. Platelet and immune cell activation
contribute to organ injury during sepsis, but the
mechanisms by which bacterial virulence factors
initiate these responses remain poorly defined. We
demonstrate that during lethal sepsis, Staphylo-
coccus aureus a-toxin simultaneously alters platelet
activation and promotes neutrophil inflammatory
signaling through interactions with its cellular recep-
tor ADAM10. Platelet intoxication prevents endothe-
lial barrier repair and facilitates formation of injurious
platelet-neutrophil aggregates, contributing to lung
and liver injury that is mitigated by ADAM10 deletion
on platelets and myeloid lineage cells. While platelet-
or myeloid-specific ADAM10 knockout does not alter
sepsis mortality, double-knockout animals are highly
protected. These results define a pathway by which a
single bacterial toxin utilizes a widely expressed re-
ceptor to coordinate progressive, multi-organ dis-
ease in lethal sepsis. As an expression-enhancing
ADAM10 polymorphism confers susceptibility to se-
vere human sepsis, these studies highlight the im-
portance of understanding molecular host-microbe
interactions.
INTRODUCTION
Bacterial sepsis is a significant cause of infectious disease mor-
tality worldwide (Angus and van der Poll, 2013). Among the path-
ogens associated with human sepsis, Staphylococcus aureus
remains the leading etiologic agent, associated with the highest
mortality (Ani et al., 2015). The success of S. aureus as an intra-
vascular pathogen depends on virulence factors that contribute
to immunoevasion and promote survival in the bloodstream
(Powers and Bubeck Wardenburg, 2014). S. aureus disables
circulating immune cells (Okumura and Nizet, 2014), inhibits
complement (Spaan et al., 2013), alters coagulation (Bhakdi
et al., 1988; McAdow et al., 2012), and attaches to the vascularCell Hendothelium (Edwards et al., 2010). To develop strategic ap-
proaches for the prevention of sepsis, detailed knowledge of
the molecular mechanisms by which specific virulence factors
perturb complex multi-cellular interactions in the vasculature is
required.
S. aureus a-toxin (Hla) is a secreted, pore-forming cytotoxin
expressed by most human disease isolates (Berube and Bubeck
Wardenburg, 2013). Hla interacts with its receptor ADAM10 to
facilitate cellular injury (Wilke and Bubeck Wardenburg, 2010).
ADAM10 is a widely expressed zinc-dependent metalloprotease
that contributes to tissue barrier regulation, cell migration and
differentiation, and control of cellular activation through enzy-
matic cleavage of the extracellular domain of its substrates
(Reiss and Saftig, 2009). The Hla-ADAM10 interaction leads
to ADAM10 activation, resulting in pathologic cleavage of
ADAM10 substrates E-cadherin on epithelial cells and endothe-
lial VE-cadherin (Inoshima et al., 2011, 2012; Powers et al.,
2012). Thesemolecular events culminate in tissue barrier disrup-
tion, exacerbating S. aureus pneumonia and dermonecrotic skin
injury and contributing to vascular leakage (Inoshima et al., 2011,
2012; Powers et al., 2012). Conditional ADAM10 knockout in
the pulmonary epithelium and epidermal keratinocytes blunts
disease, and an active-site inhibitor of ADAM10 improves the
outcome of lethal invasive disease and severe skin infection (In-
oshima et al., 2011, 2012; Powers et al., 2012; Sampedro et al.,
2014). Illustrating the tissue specificity of Hla cellular action, loss
of ADAM10 expression on myeloid lineage cells exacerbates
skin infection, but mitigates pneumonia (Becker et al., 2014).
Analysis of ADAM10 polymorphisms in human sepsis revealed
that the C allele of the rs653765 ADAM10 promoter polymor-
phism confers susceptibility to the most severe forms of disease
(Cui et al., 2015). The CC rs653765 genotype was associated
with significantly higher ADAM10 expression and a concomitant
increase in ADAM10 substrates CX3CL1, IL-6R, and TNFa,
underscoring the importance of a detailed molecular under-
standing of the Hla-ADAM10 interaction in lethal S. aureus
sepsis.
In contrast to single-organ system disease, sepsis is associ-
ated with multi-organ dysfunction. Diffuse endothelial injury
is thought to underlie systemic injury in sepsis, contributing
to organ-specific disease manifestations (Lee and Slutsky,
2010). Injury of the pulmonary endothelium triggers neutrophil
infiltration, microvascular aggregation of activated plateletsost & Microbe 17, 775–787, June 10, 2015 ª2015 Elsevier Inc. 775
and neutrophils, hemorrhage, and extravasation of protein-
rich fluid into the airspace, referred to as sepsis-associated
acute lung injury (Matthay and Zemans, 2011). Similarly, injury
of the liver sinusoidal endothelium facilitates platelet aggrega-
tion and activation of Kupffer cells and recruited neutrophils,
leading to inflammatory cytokine release (Nesseler et al.,
2012; Singer et al., 2006). Endothelial activation through
inflammation or injury initiates the platelet repair response,
marginalizing platelets and facilitating adhesion to sub-endo-
thelial collagen (Lee and Slutsky, 2010). The platelet-collagen
interaction delivers a potent platelet activation signal, resulting
in release of prothrombotic, proinflammatory mediators from
granule stores to further augment platelet activation and
thrombus formation (Li et al., 2010). Platelet activation contrib-
utes to innate immunity through antimicrobial peptide release
(Yeaman, 2010), bacterial trapping against liver sinusoidal
macrophages in sepsis (Wong et al., 2013), and promotion
of platelet-neutrophil aggregate (PNA) formation that facili-
tates neutrophil extracellular trap extrusion (Caudrillier et al.,
2012). Mirroring circulating platelets, innate immune cells
also interact with activated endothelial cells (Ley et al.,
2007). Macrophages recruit neutrophils to sites of injury where
they aid in host defense and augment inflammation by elabo-
ration of cytokines and reactive oxygen species (Mantovani
et al., 2011; McDonald et al., 2013). While platelet and immune
cell activation contributes to organ-specific pathogenesis dur-
ing sepsis, the role of specific bacterial virulence factors in
these processes remains unknown.
The broad expression profile of ADAM10 suggests that
a-toxin may contribute to progressive, multi-organ disease
observed in lethal sepsis by simultaneously targeting multiple
host cells in bloodstream, causing a synergistic injury. Platelet
activation by Hla triggers granule release and the formation of
PNAs in vitro (Bhakdi et al., 1988; Parimon et al., 2013), also
stimulating IL-1b secretion by monocytes, macrophages, and
neutrophils (Bhakdi et al., 1989; Nygaard et al., 2013). Our
knowledge of Hla-mediated destruction of the endothelial
barrier (Powers et al., 2012) led us to hypothesize that pleio-
tropic targeting of these distinct cell populations by Hla may
underlie sepsis progression. We therefore employed a genetic
strategy to understand the role of the Hla-ADAM10 complex
on multiple hematopoietic lineages during lethal bloodstream
infection.
RESULTS
Hla Impairs Platelet Aggregation through Glycoprotein
Modification
Vascular injury poses a threat of hemorrhage, necessitating a
rapid, multi-step repair process initiated by platelet adherence
to von Willebrand factor (vWF) extruded from endothelial cells.
We reasoned that endothelial injury promoted by the Hla-
ADAM10 complex should prompt a rapid platelet response to
restore vascular integrity. We evaluated this process in human
pulmonary artery endothelial cells (HPAECs) following exposure
to Hla or its non-toxinogenic variant (HlaH35L) that fails to form a
lytic pore or activate the metalloprotease (Inoshima et al., 2011;
Wilke and Bubeck Wardenburg, 2010). vWF was extruded upon
treatment with Hla or histamine, an agonist of vWF deposition776 Cell Host & Microbe 17, 775–787, June 10, 2015 ª2015 Elsevier(Figure 1A, red), whereas vWF was not observed following treat-
ment with HlaH35L or the ADAM10 inhibitor GI254023X that
blocks toxin action (Figure 1A). We next examined whether
vWF release enhanced platelet-endothelial interactions in a
flow chamber systemwhere labeled human platelets were circu-
lated over toxin-treated HPAECs. The addition of a sub-cytolytic
concentration of Hla, but not HlaH35L, caused platelet-endothe-
lial tethering within 30 min (Figure 1B).
To further analyze Hla action on platelets, we examined down-
stream mechanisms of platelet-dependent endothelial repair.
Platelet-vWF tethering promotes the interaction of platelet glyco-
protein VI (GPVI) with exposed sub-endothelial collagen, aug-
menting platelet activation (Nieswandt et al., 2001). We utilized
the flow-based system toexaminewhetherHlamodulates platelet
binding to type-1 fibrillar collagen. HlaH35L-treated platelets
adhered to collagen and formed aggregates over 60min,whereas
Hla-treated platelets displayed limited collagen interaction (Fig-
ure 1C). This finding was reminiscent of the impaired platelet-
collagen interaction observed in human GPVI deficiency (Moroi
and Jung, 2004). As GPVI is a native ADAM10 substrate (Bender
et al., 2010), we examined human platelet ADAM10 activity
following toxin treatment. Hla led to increased ADAM10 activity
(Figure 1D), triggering GPVI proteolysis detectable by release
of the N-terminal extracellular fragment (Figure 1E, NTF).
Collagen-bound GPVI engenders platelet morphologic changes
and upregulates GPIIb-IIIa-dependent adhesion to fibrinogen to
facilitate platelet-platelet interactions (Li et al., 2010). Collagen
treatmentofhumanplatelets led toactivatedGPIIb-IIIa expression
(Figure 1F, gray line), while Hla pre-treatment abrogated this
response (black line), consistentwithGPVI loss. HlaH35L pre-treat-
ment did not impair GPIIb-IIIa activation (dotted line). Hla also
impaired collagen-induced platelet aggregation on fibrinogen
(Figure 1G).
ADAM10 Is Required for Modification of Platelet
Adhesion by Hla
Multiple stimuli contribute to platelet activation via ligand en-
gagement of platelet surface receptors (Li et al., 2010). In
response to Hla, platelets secrete alpha- and dense-granules,
which are effectors of activation (Bhakdi et al., 1988). To examine
the necessity of ADAM10 in platelet activation by Hla, we gener-
ated mice harboring platelet-specific ADAM10 deletion utilizing
platelet factor 4 (PF4) promoter-driven Cre recombinase expres-
sion (Figure S1A, ADAM10), and confirmed loss of ADAM10
expression in knockout mice (Figure S1B, PF4 ADAM10/).
Loss of platelet ADAM10 expression did not alter hematopoiesis,
consistent with prior studies (Bender et al., 2010) (Figures S1C–
S1F). ADAM10/ platelets were Hla-insensitive measured by
LDH (Figure S1G) and ATP release (Figure S1H); however, they
remained responsive to collagen (Figure S1I). ADAM10/ plate-
lets displayed a marked reduction in cell-associated metallopro-
tease activity upon toxin treatment in contrast to control platelets
(Figure S1J).
We hypothesized that loss of platelet ADAM10 expression
would preserve the adhesive properties of Hla-treated platelets,
maintaining platelet-collagen and platelet-platelet interactions.
We thus examined physiologic adhesive events mediated by
platelet GPVI and GPIIb-IIIa in control and ADAM10/ platelets
in response to Hla. While control platelets exhibited a loss ofInc.
Figure 1. Hla Alters Platelet Aggregation
(A) von Willebrand factor (red) release from primary human pulmonary artery endothelial cells (HPAECs) was assessed following stimulation with histamine,
HlaH35L, Hla, or Hla in the presence of the ADAM10 inhibitor GI254023X or vehicle control DMSO. Dapi (blue) denotes cell nuclei.
(B) Quantification of calcein AM-labeled human platelets that adhere to HlaH35L or Hla-treated HPAECs as in (A), ****p% 0.0001.
(C) Adherence of Hla or HlaH35L-treated calcein AM-labeled platelets to collagen-coated slides.
(D) Toxin-induced metalloprotease activity in platelets stimulated with Hla in the presence of a fluorogenic ADAM10 substrate for 30 min, *p% 0.05.
(E) GPVI immunoblot analysis of lysates prepared from human platelets treated with HlaH35L or Hla. FL, full-length GPVI; NTF, N-terminal GPVI fragment.
(F) Activated GPIIb-IIIa expression on human platelets pre-treated with Hla (black line) or HlaH35L (dotted line) followed by treatment with collagen compared to
collagen-alone control (gray line).
(G) Aggregation of calcein AM-labeled platelets on plate-bound human fibrinogen following treatment as in (C). Scale bars, 10 mm. Data are represented as
mean ± SD.GPVI expression upon Hla exposure, ADAM10/ platelets
maintained GPVI (Figure 2A). Consistent with GPVI cleavage,
toxin-treated control platelets did not bind fibrillar collagen
under flow conditions, while ADAM10/ platelets were readily
adherent (Figure 2B). Soluble and plate-bound collagen are
potent stimuli for human platelet activation ex vivo; however,
mouse platelets are optimally stimulated by a peptide derived
from collagen (collagen-related peptide, CRP). Hla pre-treated
control platelets failed to display activated GPIIb-IIIa in response
to CRP (Figure 2C, left panel, black line), in contrast to HlaH35L
pre-treated platelets (dotted line) or CRP alone (gray line).
ADAM10/ platelets were Hla resistant, expressing activated
GPIIb-IIIa following CRP treatment (Figure 2C) and preserving
fibrinogen binding (Figure 2D).Cell HPlatelet Intoxication Contributes to Sepsis-Associated
Acute Lung Injury
Acute lung injury is a common complication of sepsis and other
systemic injuries, in which disturbances of platelet function
contribute to pathology (Looney et al., 2009; Zarbock et al.,
2006). To assess whether alterations in platelet adhesion by
Hla modulate S. aureus sepsis-associated ALI, we examined
lung pathology in control and PF4 ADAM10/mice following le-
thal intravenous challenge with S. aureus USA300, an epidemic
human isolate. Control mice demonstrated intrapulmonary hem-
orrhage 4 hr post-infection (Figure 2E, black arrows). While red
cells are visualized in the capillaries of infected PF4 ADAM10/
mice (Figure 2F, yellow arrows), these mice do not develop overt
hemorrhage (Figure 2F). Consistent with decreased pathologicost & Microbe 17, 775–787, June 10, 2015 ª2015 Elsevier Inc. 777
Figure 2. ADAM10 Alters Platelet Adhesive Properties in Response to Hla and Contributes to Sepsis-Associated Lung Injury
(A) GPVI expression on control or PF4 ADAM10/ platelets following treatment with HlaH35L or Hla, **p% 0.01. Data are represented as mean ± SD.
(B) Adherence of control or PF4 ADAM10/ platelets flowed over plate-bound collagen following treatment with HlaH35L or Hla. Scale bars, 10 mm.
(C) Analysis of activated GPIIb-IIIa expression on control (left) or PF4 ADAM10/ (right) platelets pre-treated with Hla (black line) or HlaH35L (dotted line) followed
by treatment with collagen-related peptide (CRP). CRP alone (gray line), untreated (gray shading) platelets served as controls.
(D) Binding of FITC-labeled fibrinogen to control and PF4 ADAM10/ platelets treated as in (C).
(legend continued on next page)
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evidence of ALI, we also observed a reduction in bronchoalveo-
lar protein extravasation in PF4 ADAM10/mice relative to con-
trols (Figure 2G). Our observation that Hla perturbs platelet adhe-
sion and promotes lung injury suggests that Hla renders platelets
less adherent to sites of microvascular injury in sepsis. We there-
fore visualized platelets in the lungs 4 hr post-infection. Control
mice display a reduction in platelet accumulation compared to
knockout mice, suggesting a defect in adhesive function of
Hla-sensitive platelets (Figures 2H and 2I). These early manifes-
tations of ALI in control mice relative toPF4ADAM10/mice are
accompanied by greater recovery of S. aureus from saline-
perfused lungs, a measure of bacteria that are firmly attached
to the vasculature or lung tissue (Figure 2J). Consistent with
toxin-mediated exacerbation of ALI, mice infected with Hla-defi-
cient S. aureus exhibited decreased alveolar hemorrhage (Fig-
ures S2A and S2B), bronchoalveolar protein (Figure S2C), and
S. aureus recovery (Figure S2D). The increased dissemination
of wild-type bacteria into the lung does notmerely reflect a differ-
ential bloodstream load (Figure S2E).
Hla Augments Host Inflammation through PNA
Formation
The functional role of platelet adhesion is not limited to endothe-
lial repair, as activated platelets also adhere to neutrophil PSGL-
1 through surface display of P-selectin extruded from a-granules
(Brown et al., 1998). We hypothesized that perturbation of
platelet activation by Hla may broadly alter inter-cellular interac-
tions and host inflammation. Treatment of control platelets with
CRP and Hla led to P-selectin expression within 15 min, in
contrast to HlaH35L treatment (Figure 3A, mouse; and Figure 3B,
human). PF4 ADAM10/ platelets failed to express P-selectin in
response to Hla (Figure 3A), while this response was preserved
to CRP. To examine the Hla-ADAM10 complex in PNA formation,
we utilized a whole-blood flow-cytometric approach examining
co-staining with neutrophil-specific markers (GR1, mouse; or
CD11b, human) and platelet GPIba. To detect PNAs, gated
GR1+ or CD11b+ cells were examined for associated platelets
(population gating, Figure S3A). In murine cells, the baseline
detection of neutrophils (GR1 staining, Figure 3C, left) and PNA
(GR1+/ GPIba+ population, untreated) was similar between con-
trol (upper panel) andPF4 ADAM10/ (middle panel) mice. Like-
wise, CRP treatment induced a GR1+/GPIba+ PNA population in
both groups of mice. HlaH35L treatment mirrored the untreated
GR1+/GPIba+ cell population, while Hla treatment of control
blood enhanced PNA formation (upper panel). In contrast, Hla
treatment of blood harvested from PF4 ADAM10/ mice did
not enhance the GR1+/GPIba+ population (middle panel), indic-
ative of the role of the platelet toxin-receptor complex in trig-
gering PNA formation. In human cells, the presence of PNA(E) H&E-stained lung sections from control or PF4 ADAM10/mice 4 hr after infe
of greater than three mice per condition from two independent experiments.
(F) Higher-magnification images of lung sections in (E), where yellow arrows dem
bars, 100 mm (upper) and 20 mm (lower).
(G) Protein content in bronchoalveolar lavage (BAL) fluid from control (n = 12) an
(H) Platelets and nuclei (blue, dapi) in control or PF4 ADAM10/ lungs 4 hr post
(I) Quantification of platelets per frame from control or PF4 ADAM10/ lungs (n
(J) S. aureus colony-forming unit (CFU) recovery from lung tissue 4 hr after infectio
are represented as mean ± SD; see also Figures S1 and S2.
Cell Hformation indicated by a CD11b+/GPIba+ population was simi-
larly observed upon Hla treatment in the presence of neutrophils
(Figure 3C, lower panel) (Parimon et al., 2013).
PNA formation stimulates chemokine and cytokine synthesis
(Neumann et al., 1997; Weyrich et al., 1996). We have previously
observed that murine neutrophils resist lytic intoxication,
demonstrating that the Hla-ADAM10 interaction on neutrophils
primarily triggers IL-1b release (Becker et al., 2014). Similarly, hu-
man neutrophils exhibit resistance to the lytic effects of Hla rela-
tive to human platelets (Figure S3B) (Nygaard et al., 2013; Valeva
et al., 1997). We hypothesized that neutrophil stimulation by
adherent platelets in concert with Hla may augment neutrophil
cytokine production, leading to a state of enhanced inflamma-
tion. To assess this, neutrophils were incubated with untreated
platelets or platelets stimulated for 4 hr with a low concentration
of Hla (0.1 mg/ml) to promote PNA formation. Platelet-neutrophil
suspensions were then left untreated or treated with a toxin con-
centration (25 mg/ml) that stimulates neutrophil IL-1b release
(Becker et al., 2014). Both mouse and human neutrophils stimu-
lated with toxin-pre-treated platelets produced significantly
more IL-1b (Figure 3D, mouse; and Figure 3E, human, black)
and IL-18 (white) in response to Hla (Neut.+Plat.(0.01)+Hla(25))
compared to toxin-treated neutrophils alone (Neut.(25)). IL-1b
and IL-18 production by unexposed cells (Neut.+Plat.) or neutro-
phils and platelets only exposed to low Hla concentrations
(Neut.+Plat.(0.01)) confirmed the synergistic release of IL-1b
and IL-18 elicited from toxin-exposed neutrophils engaged in
PNA. Limited cytokine release was observed upon neutrophil
exposure to pre-treated platelets alone (Neut.+Plat.(0.01), Fig-
ure 3D) or platelets exposed to Hla (Plat.(0.01), Figure 3D).
a-toxin contributes to activation of the NLRP3 inflammasome,
leading to caspase-1 cleavage and production of mature IL-1b
and IL-18 in macrophages and in the context of S. aureus
infection of mice (Craven et al., 2009; Kebaier et al., 2012; Mu-
n˜oz-Planillo et al., 2009). To examine the role of caspase-1 acti-
vation in PNA-mediated cytokine release downstream of the
Hla-ADAM10 complex, we utilized mice harboring a caspase 1
deletion (Caspase 1/4/, de facto caspase 4 deletion) (Kuida
et al., 1995). Neutrophils from Caspase 1/4/ mice exposed to
platelets andHla failed toelicit a robust IL-1b responsecompared
to controls (Figure 3F) demonstrating the vital role of thecaspase-
mediated pathway in toxin-stimulated inflammatory cytokine
production by PNA. Stimulation of control or PF4 ADAM10/
platelets with a low concentration of Hla in the presence of
neutrophils, followed by neutrophil stimulation with Hla, revealed
that only control platelets facilitated synergistic IL-1bproduction,
confirming the necessity of host ADAM10 in this pathway
(Figure 3G, where dotted line indicates neutrophils alone
treated with Hla). Consistent with this pro-inflammatory effectction with S. aureus USA300. Scale bars, 1,000 mm, and images representative
onstrate red cells in the vasculature of PF4 ADAM10/-infected mice. Scale
d PF4 ADAM10/ (n = 9) mice infected as in (E), **p% 0.01.
infection as in (E). Scale bars, 10 mm.
= 3) of the images (n = 20) in (H).
n of control (n = 8) and PF4 ADAM10/ (n = 9) mice as in (E), **p% 0.01. Data
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Figure 3. Hla Promotes PNA Formation
(A and B) P-selectin expression on mouse (A) and human (B) platelets following treatment with collagen-related peptide (CRP), HlaH35L, or Hla; **p % 0.01,
****p% 0.0001.
(C) PNA formation from control and PF4 ADAM10/mice (GR1+/GPIba+) or humans (CD11b+/GPIba+) either left untreated or treated with CRP, HlaH35L, or Hla.
(D–G) IL-1b (black) and IL-18 (white) production following PNA formation in platelet-neutrophil suspensions from wild-type mice (D), human (E), control and
Caspase 1/4/ mice (F), or control and PF4 ADAM10/ mice (G); (D) and (E) *p% 0.05, **p% 0.01 compared to Neut. or Neut.+Plat. (F) and (G) *p% 0.05,
**p% 0.01 compared to control, where dotted line denotes the response of control neutrophils to Hla. Data are represented asmean ± SD. In (D)–(G), (0.1) and (25)
denote treatment with toxin concentrations in mg/ml.
(H) NET release examined in mouse platelet-neutrophil suspensions treated as in (D)–(G) or with phorbol myristate acetate (PMA). See also Figure S3.
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Figure 4. Hla Targets Platelets and Myeloid Cells in the Liver to Stimulate IL-1b Production
Liver IL-1b analysis 72 hr post infection of PF4 ADAM10/ (A), LysM ADAM10/ (B), and PF4/LysM ADAM10/ (C) or corresponding controls, *p % 0.05,
**p% 0.01. Data are represented as mean ± SD; see also Figures S4 and S5.of toxin-activated platelets, simultaneous exposure of neutro-
phils to platelets and Hla resulted in neutrophil extracellular trap
release (NETs, Figure 3H) (Clark et al., 2007). In contrast, neutro-
phils exposed to an Hla concentration that facilitates PNA forma-
tion (1 mg/ml) or platelets alone did not release NETs (Figure 3H),
while NET release was confirmed with PMA treatment.
The ADAM10-Hla Interaction Augments Liver IL-1b
Production
These data indicate that Hla alters platelet activation, abrogating
the beneficial function of platelets in vascular repair while
inducing a potentially deleterious pro-inflammatory state by
augmenting platelet-neutrophil interactions and enhancing the
potency of Hla on neutrophils. Within the liver, immune cell
activation and Kupffer cell-mediated neutrophil recruitment
enhance inflammatory cytokine production and hepatocellular
injury (Nesseler et al., 2012). As S. aureus sepsis initiates a rapid
interaction of platelets and innate immune cells in the hepatic
vasculature (Wong et al., 2013), we evaluated liver inflammation
by examining tissue-specific IL-1b induction in septic PF4
ADAM10/ mice or myeloid lineage-specific ADAM10/ mice
(LysM ADAM10/) (Becker et al., 2014) 72 hr post-infection.
Both PF4 ADAM10/ (Figure 4A) and LysM ADAM10/ (Fig-
ure 4B) mice demonstrated a decrease in liver IL-1b compared
to controls. Diminished IL-1b production in LysM ADAM10/
mice was not attributable to altered platelet-neutrophil interac-
tions (Figure S4A). These findings suggest that concomitant
intoxication of both cell types in the septic liver may facilitate
maximal IL-1b production during infection. To extend these
studies, we generated mice harboring simultaneous deletion of
ADAM10 in both lineages (PF4/LysMADAM10/). Similar to sin-
gle-knockout mice, liver IL-1b production was significantly
decreased in septic PF4/LysM ADAM10/ mice (Figure 4C).
This responsewas IL-1b specific, aswedid not detect alterations
in TNF-a or IL-10 (Figures S4B and S4C).
PF4/LysM ADAM10 Mice Are Protected from
Multi-Organ Injury
We have demonstrated that Hla contributes to sepsis-associ-
ated lung and liver injury dependent on hematopoietic cell target-
ing. We hypothesized that PF4/LysM ADAM10/ mice would
exhibit reduced pathologic signs ofmulti-organ injury associated
with lethal sepsis. Indeed, fewer areas of overt alveolar hemor-
rhage were observed in these mice compared to controls
(Figure 5A), with a reduction in proteinaceous edema in dou-Cell Hble-knockout mice (392 ± 99 mg/ml in control versus 130 ±
22 mg/ml in PF4/LysM ADAM10/) mirroring PF4 ADAM10/
mice. Lungs from LysM ADAM10/ single-knockout mice re-
mained susceptible to lung injury with BAL fluid protein (Fig-
ure S5A) and bacterial extravasation (Figure S5B) as controls,
suggesting that platelet intoxication is a predominant contributor
to ALI. Similarly, liver injury was reduced in PF4/LysM
ADAM10/ mice. While control livers displayed large areas of
necrosis (Figure 5B, arrows), double-knockout mice experi-
enced a lesser degree of liver injury following infection. Glycogen
depletion, a marker of liver stress, wasmore prominent in control
than PF4/LysM ADAM10/ mice (Figure 5C, reduced PAS
staining [magenta], noted by yellow arrows). Control mice
demonstrated increased cellular apoptosis measured by active
caspase-3 staining of liver sections (Figure 5D, brown) and
elevated myeloperoxidase activity (MPO) in liver homogenates
compared to PF4/LysM ADAM10/ mice (Figure 5E). Assign-
ment of pathology scores to quantify liver injury based on
the markers described above in addition to hepatocyte vacuola-
tion confirmed the protection conferred in double-knockout
mice (Figure 5F). This reduction in liver injury was reflected
as decreased serum alanine aminotransferase in PF4/LysM
ADAM10/ mice (Figure 5G).
Hla Targets Platelets and Myeloid Cells to Cause
Lethality
The contribution of Hla to multi-organ injury in sepsis led us to
examine the role of simultaneous targeting of platelets and
myeloid lineage cells in relation to mortality. Double-knockout
mice were highly protected against lethal sepsis (Figure 6A).
In contrast, PF4 ADAM10/ and LysM ADAM10/ single-
knockout mice succumbed as control mice (Figures 6B and
6C). Survival of double-knockout mice is not simply a byproduct
of decreased bacterial load as S. aureus recovery from multiple
organs was comparable in control and PF4/LysM ADAM10/
mice 3 days post-infection (Figures S6A–S6D). While these
data suggest that Hla targeting of both platelets and myeloid
lineage cells contributes to a synergistic increase in sepsis
mortality, each of these cell populations remains vital for innate
immunoprotection against S. aureus infection. Independent
depletion of platelets, neutrophils, or macrophages renders
C57Bl/6 mice fully susceptible to lethal sepsis (Figures S7A–
S7C, respectively). Moreover, IL-1 receptor-deficient (IL-1R/)
and Caspase 1/4/ mice exhibit increased susceptibility to le-
thal infection (Figures S7D and S7E, respectively).ost & Microbe 17, 775–787, June 10, 2015 ª2015 Elsevier Inc. 781
(legend on next page)
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A B C
Figure 6. Hla Targets Platelets and Myeloid Lineage Cells to Contribute to Lethal Sepsis
Survival following lethal S. aureus infection in PF4/LysMADAM10/ (A, n = 7), PF4 ADAM10/ (B, n = 7), LysM ADAM10/ (C, n = 7), or corresponding controls
(n = 7, 7, and 8, respectively); **p% 0.01. See also Figure S7.DISCUSSION
Severe bacterial sepsis remains a leading cause of infectious
disease mortality. Modulation of the host response has been
the primary focus of novel sepsis therapies, attempting to
dampen the host pro-inflammatory response or mitigate endo-
thelial dysfunction and coagulopathy (Angus and van der Poll,
2013). The inadequacy of these approaches is thought to reflect
disease heterogeneity and gaps in our understanding of patho-
physiology, especially related to pathogen-specific responses
(Angus, 2011). Our studies of S. aureus a-toxin and its cognate
receptor ADAM10 provide insight on the fundamental molecular
mechanisms that underlie staphylococcal sepsis. The Hla-
ADAM10 complex appears to contribute to intravascular injury
through a three-pronged approach—initiation of endothelial
injury (Powers et al., 2012), perturbation of platelet-mediated
endothelial repair, and synergistic activation of pro-inflammatory
pathways by infiltrating immune cells (Figure 7A). The demon-
stration that a single bacterial toxin can simultaneously alter
discrete cellular processes on multiple cell types through a
widely expressed receptor highlights a previously unrecognized
role for bacterial toxins in coordination of disease within a tissue
environment.
This study extends our observations on the pathologic out-
comes of toxin-dependent ADAM10 activation, identifying
GPVI as a target of the toxin-receptor complex. Hla activates
platelets at sub-cytolytic concentrations (Bhakdi et al., 1988)
and augments formation of infective endocarditis thrombi (Bayer
et al., 1997). While our findings in ADAM10 knockout platelets
confirm toxin-induced activation, we observe a mechanism by
which Hla blunts GPIIb-IIIa activation through GPVI proteolysis.
Loss of GPIIb-IIIa expression precipitates a bleeding disorder
in humans and experimental animals, as mutant platelets fail toFigure 5. The Hla-ADAM10 Interaction on Platelets and Myeloid Cells
(A) H&E-stained lung sections from control or PF4/LysM ADAM10/mice 4 hr af
mice per condition from two independent experiments.
(B) H&E-stained liver sections from control or PF4/LysM ADAM10/ mice 72 hr
(C and D) Images of periodic-acid Schiff stain (PAS, C) or activated caspase-3 imm
100 mm (larger image) and 20 mm (inset); images representative of greater than fi
(E) Liver myeloperoxidase activity in control (n = 16) or PF4/LysM ADAM10/
**p% 0.01.
(F) Liver pathology scores from mice as in (B)–(D). Data represent two independe
(G) Serum alanine aminotransferase in infected control (n = 13) or PF4/LysM AD
periments, *p% 0.05. Data are represented as mean ± SD; see also Figure S6.
Cell Hestablish fibrinogen-based platelet bridges required for aggre-
gation and plugging of the injured endothelium (Tronik-Le Roux
et al., 2000). Thus, while platelet activation should restore endo-
thelial barrier function, early S. aureus infection is paradoxically
associated with hemorrhage as toxin-induced platelet activation
is uncoupled from platelet aggregation by the Hla-ADAM10
complex.
Platelets adhere to S. aureus via GPIIb-IIIa (Herrmann et al.,
1993), and also utilize the activated integrin to rapidly trap bac-
teria in liver sinusoids through GPIb- and GPIIb-mediated inter-
actions with resident macrophages or Kupffer cells (Wong
et al., 2013). The loss of this interaction in GPIb- or GPIIb-defi-
cient mice is associated with increased mortality, bacterial
burden, and liver injury after B. cereus infection (Wong et al.,
2013). Congruent with this observation, platelet depletion in-
creases S. aureus infection mortality (Wong et al., 2013). These
findings suggest that the improved outcomes we report in PF4/
LysM ADAM10/ mice may in part result from maintenance of
activated glycoprotein expression that promotes bacterial clear-
ance. While we do not observe altered tissue bacterial recovery
following lethal infection, this outcome may be more readily
evident in sub-lethal challenge.
In contrast to the beneficial role of platelets and myeloid line-
age cells in bacterial clearance, recent evidence indicates that
heterotypic PNAs exacerbate tissue injury (Caudrillier et al.,
2012). Inhibition of aggregate formation in sepsis or acid-
induced acute lung injury decreased immune cell infiltration
and vascular permeability in the lung (Looney et al., 2009; Zar-
bock et al., 2006), and provided protection against pulmonary
vascular permeability in a murine model of sickle cell disease
(Polanowska-Grabowska et al., 2010). Platelet activation by
Hla has previously been shown to promote the formation of
PNAs (Parimon et al., 2013); however, our studies demonstrateContributes to Multi-Organ Injury
ter intravenous S. aureus infection. Images representative of greater than three
after infection.
unohistochemistry (D) of liver sections frommice as in (B). In (A)–(D) scale bars,
ve mice per condition from two independent experiments.
(n = 10) mice as in (B). Data represent two independent pooled experiments,
nt pooled experiments, **p% 0.01.
AM10/ (n = 13) mice as in (B). Data represent two independent pooled ex-
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Figure 7. Model Depicting Multi-Cellular Targeting of S. aureus Hla in Sepsis
(A) S. aureus a-toxin contributes to temporospatial lung and liver injury by preventing adequate platelet repair and exacerbating the host inflammatory response.
(B) Consequences of selective deletion of ADAM10 on platelets or myeloid lineage cells.that this interaction primes the neutrophil for caspase-depen-
dent pro-inflammatory cytokine production and NET formation
in response to Hla. Liver injury attributable to the toxin appears
closely associated with this pro-inflammatory state. Hla acti-
vates the NLRP3 inflammasome to stimulate IL-1b secretion
(Craven et al., 2009; Kebaier et al., 2012; Mun˜oz-Planillo
et al., 2009). In S. aureus infection, myeloid lineage-specific
ADAM10 knockout (Becker et al., 2014) or genetic disruption
of Nlrp3 affords protection against disease, corresponding to
a reduction in inflammatory cytokine generation (Craven et al.,
2009; Kebaier et al., 2012). We demonstrate that increased liver
IL-1b production and hepatic injury in sepsis correlate with
platelet and myeloid lineage Hla susceptibility, a finding that is
consistent with the recently described role of ADAM10 in me-
prin b-driven pro-inflammatory cytokine production (Li et al.,
2014). While IL-1 receptor signaling is required for protection
during bloodstream staphylococcal infection (Hultgren et al.,
2002), hyper-inflammatory responses in the liver result in
microvascular accumulation of neutrophils, which leads to
acute liver injury (Ramaiah and Jaeschke, 2007). We do not
observe differences in liver IL-1b production between PF4/
LysMADAM10/mice that survive sepsis and the correspond-
ing PF4 ADAM10/ or LysM ADAM10/ single-knockout
mice, suggesting that this marker of inflammation does not fully784 Cell Host & Microbe 17, 775–787, June 10, 2015 ª2015 Elsevierreflect the cumulative burden of tissue injury that results from
bloodstream toxin action. While selective ADAM10/ mice
provide an opportunity to dissect the relative contribution of
the Hla-ADAM10 interaction on discrete cell populations (Fig-
ure 7B), a complete understanding of pathogenesis will require
knowledge of the concurrent microvascular effects of other
S. aureus virulence factors, notably leukotoxins (Alonzo and
Torres, 2014) and coagulopathy-inducing coagulase and vWF
binding protein (vWBP) (McAdow et al., 2012; Thomer et al.,
2013).
Our findings provide evidence that the progression of lethal
staphylococcal sepsis results from two distinct insults that are
separable on a cellular and molecular level. First, rapid severe
disease ensues from poor initial control of bacterial infection
by the innate immune system observed upon cell depletion or
genetic ablation of essential protective inflammatory signaling
pathways. Second, perturbation of host cellular function by Hla
can dampen protective responses and enhance pro-inflamma-
tory injury. This degree of complexity provides molecular insight
on the observed failures of either antimicrobial therapies or tar-
geted immunomodulation to prevent sepsis-associated mortal-
ity in humans, and establishes a temporal framework by which
to consider bacterial insults in disease progression. Further res-
olution of these processes will require an appreciation of theInc.
spatiotemporal dynamics of toxin expression, cellular localiza-
tion to the infection site, and toxin-mediated cellular injury. As
Hla targets the endothelium, platelets, and myeloid lineage cells,
a more detailed dissection of the independent contribution of
these cell populations to toxin-mediated injury is necessary. It
is predicted from our findings that Hla-induced endothelial dam-
age may be the inciting insult that triggers platelet and immune
cell marginalization within the vasculature, rendering these cells
toxin-susceptible and potentially depleting these lineages from
other areas of the body as observed in human sepsis. Recent ev-
idence underscores the importance of endothelial targeting by
Hla during bloodstream infection, as autophagy-deficient mice
display increased ADAM10 on the endothelial cell surface and
exhibit increased susceptibility to invasive staphylococcal infec-
tion (Maurer et al., 2015). In light of these studies, endothelial-
specific deletion of ADAM10 may provide substantial protection
against sepsis by limiting the downstream consequences of Hla
on multiple cellular targets. While the ADAM10 rs653765 CC
polymorphism confers susceptibility to severe sepsis caused
by a broad array of pathogens, this clinical observation together
with our mechanistic studies on the Hla-ADAM10 complex pro-
vides the rationale for clinical genotype analysis in S. aureus
sepsis patients. Such focused studies may enable rapid genetic
evaluation of patient-specific risk for disease progression, and
thereby inform the strategic, early delivery of therapies demon-
strated in pre-clinical sepsis models to neutralize Hla or inhibit
ADAM10 activity (Powers et al., 2012).
The cellular complexity of the microvasculature, coupled
with its dense distribution in every organ, may provide an
optimized tissue microenvironment in which bacterial toxins
rapidly amplify systemic injury. Recent studies of B. anthracis
anthrax toxin lend strong support for the role of bacterial toxins
as key mediators of multi-cellular and multi-organ pathology in
sepsis. Utilizing conditional knockout mice harboring cell type-
specific deletion of the toxin receptor CMG2 utilized by
anthrax lethal toxin (LT) and edema toxin (ET), Liu et al.
demonstrate that LT targeting of cardiomyocytes and vascular
smooth muscle and ET targeting of hepatocytes contribute to
lethality (Liu et al., 2013). In contrast to this two-toxin system,
our findings on S. aureus Hla provide evidence that a single
toxin-receptor interaction elicits a highly coordinated, systemic
injury by activity on disparate cell populations in the blood-
stream. Given the common clinical findings of endothelial
injury, coagulopathy, and inflammation-induced injury in hu-
man sepsis, understanding pathogen-specific strategies for
integration of these pathways may highlight fundamental,
targetable features of disease.EXPERIMENTAL PROCEDURES
Ethics Statement
Animal and human studies were conducted in accord with protocols approved
by the University of Chicago Institutional Animal Care and Use Committee and
Institutional Review Board.
Animal Studies
PF4cre transgenic C57Bl/6 mice were bred to Adam10loxP/loxP transgenic
C57Bl/6 mice (Jackson Laboratories) to generate PF4cre Adam10loxP/loxP
mice (PF4 ADAM10/). ADAM10 myeloid lineage knockout mice
(LysM ADAM10/) (Becker et al., 2014) and caspase-1-deficient miceCell H(Caspase 1/4/) (Kuida et al., 1995) have been previously described. IL-1 re-
ceptor knockout mice (IL-1R/) were purchased from Jackson Laboratories.
S. aureus strain USA300 LAC or its isogenic Hla mutant (Inoshima et al., 2011)
was prepared to deliver an inoculum of 53 107 bacteria/100 ml via retro-orbital
intravenous injection to 6- to 8-week-old C57Bl/6 mice (Powers et al., 2012).
Tissue Analysis
BAL fluid from infected mice was collected by PBS instillation into the lungs
and measured for protein content (Inoshima et al., 2011). Lungs perfused
with 3 ml PBS or liver, heart, and spleen tissues were homogenized for
CFU enumeration by serial dilution plating or ELISA for cytokine analysis.
For histopathologic studies, H&E, periodic acid-Schiff, or caspase-3 staining
was performed on formalin-fixed tissues, or frozen lung sections were
stained with a-CD42 platelet antibody. Blinded scoring (scores ranging
from 1 to 3, with 3 representing the most severe phenotype) was performed
for liver necrosis, glycogen depletion, immune cell infiltration, and caspase-3
cleavage.
Cellular Analysis
Endothelial Studies
HPAECs (Lonza) were cultured in EBM-2 BulletKit media. Active Hla was pre-
pared as described (Wilke and Bubeck Wardenburg, 2010). HPAECs exposed
to Hla or HlaH35L (5 mg/ml) were stained with a-vWF antibody or exposed to
platelets under shear stress of 150 s1 after plating in IBIDI m-slide VI flow
chambers for platelet binding quantification. Cells were examined on an
Olympus DSU Spinning Disk Confocal Microscope.
Platelet Studies
Platelets were exposed to Hla or HlaH35L (human, 1 mg/ml; or mouse,
0.25 mg/ml) to assess collagen or fibrinogen binding in IBIDI chambers.
Platelet metalloprotease activity on 5 3 105 human or mouse platelets
was quantified utilizing an ADAM10-specific fluorogenic peptide substrate
in metalloprotease assay buffer. Platelet surface protein expression in
response to collagen and toxin treatment was evaluated by immunoblot
analysis and flow-cytometric analysis for GPVI or flow-cytometric analysis
for activated GPIIbIIIa.
Platelet-Neutrophil Studies
Mouse or human whole blood was left untreated, treated with Hla or HlaH35L or
CRP as above, then fixed prior to red cell lysis and staining for cell subset anal-
ysis. Gated GR-1+ or CD11b+ neutrophils were examined for GPIba
expression to detect PNA. For PNA cytokine production, neutrophil-platelet
suspensions were left untreated or treated with Hla (0.1 mg/ml) to facilitate
PNA formation. Suspensions then exposed to Hla (25 mg/ml) were examined
for supernatant IL-1b and IL-18 by ELISA. NET formation by PNAs on poly-
L-lysine-coated slides was assessed by fluorescence microscopy following
Hoechst staining.
Statistical Methods
Pairwise comparisons were performed using the Student’s unpaired t test or
Mantel-Cox log-rank test for comparison of survival following Kaplan-Meier
estimation. p values of less than 0.05 were considered significant. Error bars
represent ± SD.
Additional experimental details are contained within the Supplemental
Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.chom.2015.05.011.
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